ArticleAnnals of clinical and translational neurology2026
Copy Number Variants and Their Association With Intracerebral Hemorrhage Risk: A Case-Control Study.
Article in Annals of clinical and translational neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
introductionIntracerebral Hemorrhage (ICH) is a leading cause of morbidity and mortality worldwide and lacks effective therapeutic interventions. Despite previous studies, the genetic underpinnings of ICH remain poorly understood. We sought to investigate the role of copy number variants (CNVs) in ICH pathophysiology to identify novel etiological mechanisms and therapeutic targets.
methodsWe analyzed microarray data from ICH cases and controls using PennCNV software, followed by rigorous quality control and CNV validation. This case-control study explored associations between large, rare CNVs and ICH risk, examining CNVs that are genic, contain ohnologs, or span multiple genes. Functional enrichment analysis was also conducted to identify overrepresented CNVs in biological processes relevant to ICH.
resultsThe study included 649 cases and 437 controls who passed quality control. Cases were more likely to have genic CNVs compared to controls (39.6% vs. 32.5%, p value = 0.02) after adjusting for age, sex, hypertension, and admixture. In pathway analysis, CNVs associated with cholesterol biosynthesis (6.3% vs. 3.2%, p value = 0.04) and blood vessel development were more common in cases (8.2% vs. 5.3%, p value = 0.06). While associations were observed at nominal significance (p < 0.05), none withstood correction for multiple comparisons. DISCUSSION: Our study represents the first CNV analysis of ICH risk. While significant associations between large, rare CNVs and ICH risk were not established, the findings indicate potential pathways for further research. The identified trends warrant further investigation, and our methodological framework provides a foundation for future large-scale studies aimed at elucidating the role of CNVs in ICH pathogenesis and outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.